查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年美国医疗器械外包市场规模,份额,趋势分析,按服务（质量保证、合同製造）,应用（心臟病学、影像学、IVD）,类别,趋势
市场调查报告书
商品编码
1233182

2023-2030年美国医疗器械外包市场规模,份额,趋势分析,按服务（质量保证、合同製造）,应用（心臟病学、影像学、IVD）,类别,趋势

U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Services (Quality Assurance, Contract Manufacturing), By Application (Cardiology, Diagnostic Imaging, IVD), By Class, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 240 Pages | 商品交期: 2-10个工作天内

价格

美国医疗器械外包市场的增长和趋势

根据Grand View Research, Inc.的最新报告，美国医疗器械外包市场规模预计到2030年将达到585亿美元，期间以11.5%的复合年增长率扩大预测期。

由于离岸趋势的增加、对高科技医疗设备的需求不断增加以及美国对医疗设备的严格监管，该市场正在增长。

医疗器械行业始终竞争激烈，冠状动脉支架、骨科器械和伤口护理等类别日趋成熟。 由于在这些类别中进行有影响力的科学创新既困难又耗时，中小企业正在通过提供更低的价格和采用创新的商业模式来获得市场份额。 医疗设备製造商可能会选择外包业务模式来降低成本、管理业务风险和改善服务。 预计这些因素将在预测期内推动市场增长。

政府当局正在增加对基本设备研发的资助，从而推动市场发展。 根据 ClinicalTrials.gov，在全球范围内，大多数设备临床研究仅在美国进行。 在医疗器械方面，美国也正在进行大量研究。

例如，截至 2023 年 2 月，在 ClinicalTrials.gov 註册的医疗器械研究超过 25,033 项。 医疗设备製造商正在研究美国，因为它有熟练的劳动力、先进的基础设施和大量提供优质服务的 CRO。 所有这些因素都有望支撑大流行后的市场。

美国医疗器械外包市场报告重点。

  • 质量保证服务预计在预测期内的复合年增长率最快，达到 13.7%。 它是维持有效质量控制系统的必要组成部分，也是任何医疗器械製造的组成部分。
  • 根据应用情况，心臟病学部分在 2022 年将占最大份额 21.8%，因为该国日益严重的疾病负担推动了对心臟病学设备的需求。
  • 按类别划分，II 类行业预计在预测期内以 11.8% 的复合年增长率增长最快。 这是由于开发这些仪器的高度复杂性以及对开发和製造这些仪器的专家团队的需求不断增加。

内容

第 1 章调查方法及范围

  • 市场细分和范围
    • 服务
    • 应用
    • 类
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
    • 初步调查的内容
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析（模型 1）
  • 二级资讯列表
  • 主要资讯列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望

第 3 章美国医疗器械外包市场：变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 用户视角分析
    • 消费者行为分析
    • 市场影响者分析
  • 监管框架
  • 市场变量分析
    • 市场促进因素分析
      • 监管环境的变化
      • 越来越多地将医疗设备製造业务外包给新兴经济体
      • 对先进产品的需求不断增长
      • 合同製造商对国际标准的实施
      • 价格竞争加剧和降低成本的需求
      • 产品设计和工程的复杂性增加
    • 市场抑制因素分析
      • 外包期间的合规问题
      • 新兴经济体情景的变化
      • 法规和法律合规性
      • 合同义务
    • 行业问题
      • 关係管理
  • 美国医疗器械外包市场：分析工具
    • 波特的五力分析
    • PESTEL 分析
  • COVID-19 的影响和改革战略

第 4 章美国医疗器械外包市场：服务细分分析

  • 定义和范围
  • 美国医疗器械外包市场：2022 年和 2030 年市场份额分析
  • 质量保证
  • 监管咨询服务
    • 临床试验申请和产品註册
    • 监管写作和出版
    • 法定代表人
    • 其他
  • 产品设计和开发
    • 设计与工程
    • 处理中
    • 成型
    • 包装
  • 产品测试和灭菌
  • 产品实施
  • 产品升级
  • 产品维护
  • 合同製造
    • 配件製造
    • 组装製造
    • 组件製造
    • 设备製造

第 5 章美国医疗器械外包市场：应用领域分析

  • 定义和范围
  • 美国医疗器械外包市场：2022 年和 2030 年市场份额分析
  • 心臟病学
    • 一级
    • 二级
    • 三级
  • 影像诊断
    • 一级
    • 二级
    • 三级
  • 骨科
    • 一级
    • 二级
    • 三级
  • 体外诊断
    • 一级
    • 二级
    • 三级
  • 眼科
    • 一级
    • 二级
    • 三级
  • 普通外科和整形外科
    • 一级
    • 二级
    • 三级
  • 给药
    • 一级
    • 二级
    • 三级
  • 牙科
    • 一级
    • 二级
    • 三级
  • 内窥镜检查
    • 一级
    • 二级
    • 三级
  • 糖尿病护理
    • 一级
    • 二级
    • 三级
  • 其他
    • 一级
    • 二级
    • 三级

第 6 章美国医疗器械外包市场：一类分析

  • 定义和范围
  • 美国医疗器械外包市场：2022 年和 2030 年市场份额分析
  • 一级
  • 二级
  • 三级

第 7 章公司简介

  • SGS SA
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Laboratory Corporation of America Holdings
    • 公司简介
    • 服务基准
    • 战略举措
  • Eurofins Scientific
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Pace Analytical Services, Inc.
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Intertek Group plc
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Wuxi Apptec
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • North American Science Associates, LLC
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Integer Holdings Corporation
    • 公司简介
    • 财务业绩
    • 服务基准
  • ICON plc
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Sterigenics US, LLC（GTCR, LLC）
    • 公司简介
    • 服务基准
    • 战略举措
  • Charles River Laboratories
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Ava□□il Medsystems, Inc.；
    • 公司简介
    • 财务业绩
    • 服务基准
  • Active Implants.
    • 公司简介
    • 服务基准
  • Omnica Corp.
    • 公司简介
    • 财务业绩
    • 服务基准
  • Teleflex Incorporated;
    • 公司简介
    • 服务基准
    • 战略举措
  • Cantel Medical Corp. (STERIS plc)
    • 公司简介
    • 财务业绩
    • 服务基准
  • Parexel International Corporation
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Medpace
    • 公司简介
    • 财务业绩
    • 服务基准
  • Premier Research
    • 公司简介
    • 财务业绩
    • 产品基准
  • IQVIA Inc.
    • 公司简介
    • 财务业绩
    • 服务基准
Product Code: 978-1-68038-600-4

U.S. Medical Device Outsourcing Market Growth & Trends:

The U.S. medical device outsourcing market size is expected to reach USD 58.5 billion by 2030, expanding at a CAGR of 11.5% during the forecast period, according to a new report by Grand View Research, Inc. This market is growing as a result of increased offshore trends, a rise in demand for high-tech medical devices, and stringent regulation for medical devices in the U.S.

The medical device industry has always been highly competitive, and categories such as coronary stents, orthopedic devices, and wound care are moving toward maturity. As high-impact scientific innovation in the above categories is difficult to achieve and is a time-consuming process, smaller companies are gaining market share by offering low prices and introducing innovative business models. Due to the convergence of mounting challenges and changing market dynamics, medical device manufacturers are likely to opt for outsourcing business models to reduce costs, manage business risks, and improve service delivery. This factor is expected to propel market growth over the forecast period.

The government authorities have escalated funds for the research and development of essential devices, thus driving the market. The majority of clinical research globally devices are conducted in the U.S. alone according to Clinical Trials .gov. In case of the medical device also significant studies are conducted in the U.S.

For instance, as of February 2023, over 25033, research for medical devices was registered in the Clinical Trials .gov. Medical device companies are conducting research in the country owing to the availability of skilled labor and advanced infrastructure, as well as the presence of a significant number of CROs offering quality services. All these factors are expected to support the market in the post-Pandemic period.

U.S. Medical Device Outsourcing Market Report Highlights:

  • The quality assurance services are projected to exhibit the fastest CAGR of 13.7% over the forecast period. This is due to the necessity of maintaining an effective quality management system, which has become an integral part of the production of every medical device
  • Cardiology segment has held the largest share of 21.8% in 2022, based on application owing to the growing demand for cardiac devices due to the rising disease burden in the country
  • Based on class, the Class II segment is expected to grow at the fastest CAGR of 11.8% over the forecast period, owing to the high complexity in developing these devices that are promoting the demand for an expert team to conduct development and manufacturing of these devices

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.2 Service
    • 1.1.3 Application
    • 1.1.4 Class
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1: Understanding the market dynamics
    • 1.10.2 Objective - 2: Understanding the market estimates and forecasts
    • 1.10.3 Objective - 3: Understanding the attributes such as strategy framework
    • 1.10.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 U.S. Medical device Outsourcing Market: Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 User Perspective Analysis
    • 3.2.1 Consumer Behavior Analysis
    • 3.2.2 Market Influencer Analysis
  • 3.3 Regulatory Framework
  • 3.4 Market Variable Analysis
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Changing Regulatory Landscape
      • 3.4.1.2 Increase in Off-Shoring Medical Device Manufacturing to the Emerging Economies
      • 3.4.1.3 Rising Demand for the Advanced Products
      • 3.4.1.4 Implementation of the International Standards by the Contract Manufacturers
      • 3.4.1.5 Rising Price Competition and the Requirement to Reduce Cost
      • 3.4.1.6 Increasing Complexity Concerning Product Design and Engineering
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Compliance Issues While Outsourcing
      • 3.4.2.2 Changing Scenarios Within Developing Countries
      • 3.4.2.3 Regulatory and Legal Compliance
      • 3.4.2.4 Contractual Obligation
    • 3.4.3 Industry Challenges
      • 3.4.3.1 Managing Relationships
  • 3.5 U.S. Medical device outsourcing market: Analysis Tools
    • 3.5.1 Porter's Five Forces Analysis
    • 3.5.2 Pestel Analysis
  • 3.6. COVID-19 Impact and Reformation Strategies

Chapter 4 U.S. Medical Device Outsourcing Market: Services Segment Analysis

  • 4.1 Definition & Scope
  • 4.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 4.3 Quality Assurance
    • 4.3.1 Quality Assurance Services Market, 2018 - 2030 (USD Million)
  • 4.4 Regulatory Consulting Services
    • 4.4.1 Regulatory Consulting Services Market, 2018 - 2030 (USD Million)
    • 4.4.2 Clinical Trial Application and Product Registration
      • 4.4.2.1 Clinical Trial Application and Product Registration Market, 2018 - 2030 (USD Million)
    • 4.4.3 Regulatory Writing and Publishing
      • 4.4.3.1 Regulatory Writing and Publishing Market, 2018 - 2030 (USD Million)
    • 4.4.4 Legal Representation
      • 4.4.4.1 Legal Representation Market, 2018 - 2030 (USD Million)
    • 4.4.5 Others
      • 4.4.5.1 Others Market, 2018 - 2030 (USD Million)
  • 4.5 Product Design and Development
    • 4.5.1 Product Design and Development Services Market, 2018 - 2030 (USD Million)
    • 4.5.2 Designing and Engineering
      • 4.5.2.1 Designing and Engineering Market, 2018 - 2030 (USD Million)
    • 4.5.3 Machining
      • 4.5.3.1 Machining Market, 2018 - 2030 (Usd Million)
    • 4.5.4 Molding
      • 4.5.4.1 Molding Market, 2018 - 2030 (Usd Million)
    • 4.5.5 Packaging
      • 4.5.5.1 Packaging Market, 2018 - 2030 (USD Million)
  • 4.6 Product Testing and Sterilization
    • 4.6.1 Product Testing and Sterilization Market, 2018 - 2030 (USD Million)
  • 4.7 Product Implementation
    • 4.7.1 Product Implementation Market, 2018 - 2030 (USD Million)
  • 4.8 Product Upgrade
    • 4.8.1 Product Upgrade Market, 2018 - 2030 (USD Million)
  • 4.9 Product Maintenance
    • 4.9.1 Product Maintenance Market, 2018 - 2030 (USD Million)
  • 4.10 Contract Manufacturing
    • 4.10.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.2 Accessories Manufacturing
      • 4.10.2.1 Accessories Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.3 Assembly Manufacturing
      • 4.10.3.1 Assembly Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.4 Component Manufacturing
      • 4.10.4.1 Component Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.5 Device Manufacturing
      • 4.10.5.1 Device Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 5 U.S. Medical device outsourcing market: Application Segment Analysis

  • 5.1 Definition & Scope
  • 5.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 5.3 Cardiology
    • 5.3.1 Cardiology market, 2018 - 2030 (USD Million)
    • 5.3.2 Class I
      • 5.3.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.3.3 Class II
      • 5.3.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.3.4 Class III
      • 5.3.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.4 Diagnostic Imaging
    • 5.4.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
    • 5.4.2 Class I
      • 5.4.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.4.3 Class II
      • 5.4.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.4.4 Class III
      • 5.4.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.5 Orthopedic
    • 5.5.1 Orthopedic market, 2018 - 2030 (USD Million)
    • 5.5.2 Class I
      • 5.5.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.5.3 Class II
      • 5.5.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.5.4 Class III
      • 5.5.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.6 IVD
    • 5.6.1 IVD market, 2018 - 2030 (USD Million)
    • 5.6.2 Class I
      • 5.6.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.6.3 Class II
      • 5.6.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.6.4 Class III
      • 5.6.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.7 Ophthalmic
    • 5.7.1 Ophthalmic market, 2018 - 2030 (USD Million)
    • 5.7.2 Class I
      • 5.7.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.7.3 Class II
      • 5.7.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.7.4 Class III
      • 5.7.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.8 General & plastic surgery
    • 5.8.1 General & plastic surgery market, 2018 - 2030 (USD Million)
    • 5.8.2 Class I
      • 5.8.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.8.3 Class II
      • 5.8.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.8.4 Class III
      • 5.8.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.9 Drug delivery
    • 5.9.1 Drug delivery market, 2018 - 2030 (USD Million)
    • 5.9.2 Class I
      • 5.9.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.9.3 Class II
      • 5.9.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.9.4 Class III
      • 5.9.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.10 Dental
    • 5.10.1 Dental market, 2018 - 2030 (USD Million)
    • 5.10.2 Class I
      • 5.10.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.10.3 Class II
      • 5.10.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.10.4 Class III
      • 5.10.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.11 Endoscopy
    • 5.11.1 Endoscopy market, 2018 - 2030 (USD Million)
    • 5.11.2 Class I
      • 5.11.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.11.3 Class II
      • 5.11.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.11.4 Class III
      • 5.11.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.12 Diabetes care
    • 5.12.1 Diabetes care market, 2018 - 2030 (USD Million)
    • 5.12.2 Class I
      • 5.12.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.12.3 Class II
      • 5.12.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.12.4 Class III
      • 5.12.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.13 Others
    • 5.13.1 Others market, 2018 - 2030 (USD Million)
    • 5.13.2 Class I
      • 5.13.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.13.3 Class II
      • 5.13.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.13.4 Class III
      • 5.13.4.1 Class III market, 2018 - 2030 (USD Million)

Chapter 6 U.S. Medical device outsourcing market: Class Analysis

  • 6.1 Definition & Scope
  • 6.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 6.3 Class I
    • 6.3.1 Class I market, 2018 - 2030 (USD Million)
  • 6.4 Class II
    • 6.4.1 Class II market, 2018 - 2030 (USD Million)
  • 6.5 Class III
    • 6.5.1 Class III market, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

    • 7.1.1 SGS SA
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Service Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 Laboratory Corporation of America Holdings
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Service Benchmarking
      • 7.1.2.3 Strategic Initiatives
    • 7.1.3 Eurofins Scientific
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Service Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Pace Analytical Services, Inc.
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Service Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Intertek Group plc
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Service Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Wuxi Apptec
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Service Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 North American Science Associates, LLC
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Service Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 Integer Holdings Corporation
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Service Benchmarking
    • 7.1.9 ICON plc
      • 7.1.9.1 Company Overview
      • 7.1.9.2 Financial Performance
      • 7.1.9.3 Service Benchmarking
      • 7.1.9.4 Strategic Initiatives
    • 7.1.10 Sterigenics U.S., LLC (GTCR, LLC)
      • 7.1.10.1 Company Overview
      • 7.1.10.2 Service Benchmarking
      • 7.1.10.3 Strategic Initiatives
    • 7.1.11 Charles River Laboratories
      • 7.1.11.1 Company Overview
      • 7.1.11.2 Financial Performance
      • 7.1.11.3 Service Benchmarking
      • 7.1.11.4 Strategic Initiatives
    • 7.1.12 Avail Medsystems, Inc. ;
      • 7.1.12.1 Company Overview
      • 7.1.12.2 Financial Performance
      • 7.1.12.3 Service Benchmarking
    • 7.1.13 Active Implants.
      • 7.1.13.1 Company Overview
      • 7.1.13.2 Service Benchmarking
    • 7.1.14 Omnica Corp.
      • 7.1.14.1 Company Overview
      • 7.1.14.2 Financial Performance
      • 7.1.14.3 Service Benchmarking
    • 7.1.15 Teleflex Incorporated;
      • 7.1.15.1 Company Overview
      • 7.1.15.2 Service Benchmarking
      • 7.1.15.3 Strategic Initiatives
    • 7.1.16 Cantel Medical Corp. (STERIS plc)
      • 7.1.16.1 Company Overview
      • 7.1.16.2 Financial Performance
      • 7.1.16.3 Service Benchmarking
    • 7.1.17 Parexel International Corporation
      • 7.1.17.1 Company Overview
      • 7.1.17.2 Financial Performance
      • 7.1.17.3 Service Benchmarking
      • 7.1.17.4 Strategic Initiatives
    • 7.1.18 Medpace
      • 7.1.18.1 Company Overview
      • 7.1.18.2 Financial Performance
      • 7.1.18.3 Service Benchmarking
    • 7.1.19 Premier Research
      • 7.1.19.1 Company Overview
      • 7.1.19.2 Financial Performance
      • 7.1.19.3 Product Benchmarking
    • 7.1.20 IQVIA Inc.
      • 7.1.20.1 Company Overview
      • 7.1.20.2 Financial Performance
      • 7.1.20.3 Service Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in the U.S.
  • Fig. 5 Market research approaches
  • Fig. 6 Value - chain - based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 Volume Price Analysis
  • Fig. 11 U.S. medical device outsourcing market snapshot (2022)
  • Fig. 12 U.S. medical device outsourcing market segmentation
  • Fig. 13 U.S. medical device outsourcing market: Strategy framework
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Current shared services and outsourcing usage levels
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PEST Analysis
  • Fig. 21 U.S. medical device outsourcing market service outlook: Segment Dashboard
  • Fig. 22 U.S. medical device outsourcing market: Service movement analysis
  • Fig. 23 Quality assurance services market, 2018 - 2030 (USD Million)
  • Fig. 24 Regulatory Consulting Services market, 2018 - 2030 (USD Million)
  • Fig. 25 Clinical trial application and product registration market, 2018 - 2030 (USD Million)
  • Fig. 26 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
  • Fig. 27 Legal representation market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Product design and development services market, 2018 - 2030 (USD Million)
  • Fig. 30 Designing and engineering market, 2018 - 2030 (USD Million)
  • Fig. 31 Machining market, 2018 - 2030 (USD Million)
  • Fig. 32 Molding market, 2018 - 2030 (USD Million)
  • Fig. 33 Packaging market, 2018 - 2030 (USD Million)
  • Fig. 34 Product testing and sterilization market, 2018 - 2030 (USD Million)
  • Fig. 35 Product implementation market, 2018 - 2030 (USD Million)
  • Fig. 36 Product upgrade market, 2018 - 2030 (USD Million)
  • Fig. 37 Product maintenance market, 2018 - 2030 (USD Million)
  • Fig. 38 Contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Accessories manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 Component manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Device manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. medical device outsourcing market application outlook: Segment Dashboard
  • Fig. 43 U.S. medical device outsourcing market: Application movement analysis
  • Fig. 44 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 45 Class I market, 2018 - 2030 (USD Million)
  • Fig. 46 Class II market, 2018 - 2030 (USD Million)
  • Fig. 47 Class III market, 2018 - 2030 (USD Million)
  • Fig. 48 Diagnostic imaging market, 2018 - 2030 (USD Million)
  • Fig. 49 Class I market, 2018 - 2030 (USD Million)
  • Fig. 50 Class II market, 2018 - 2030 (USD Million)
  • Fig. 51 Class III market, 2018 - 2030 (USD Million)
  • Fig. 52 Orthopedic market, 2018 - 2030 (USD Million)
  • Fig. 53 Class I market, 2018 - 2030 (USD Million)
  • Fig. 54 Class II market, 2018 - 2030 (USD Million)
  • Fig. 55 Class III market, 2018 - 2030 (USD Million)
  • Fig. 56 IVD market, 2018 - 2030 (USD Million)
  • Fig. 57 Class I market, 2018 - 2030 (USD Million)
  • Fig. 58 Class II market, 2018 - 2030 (USD Million)
  • Fig. 59 Class III market, 2018 - 2030 (USD Million)
  • Fig. 60 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 61 Class I market, 2018 - 2030 (USD Million)
  • Fig. 62 Class II market, 2018 - 2030 (USD Million)
  • Fig. 63 Class III market, 2018 - 2030 (USD Million)
  • Fig. 64General & plastic surgery market, 2018 - 2030 (USD Million)
  • Fig. 65 Class I market, 2018 - 2030 (USD Million)
  • Fig. 66 Class II market, 2018 - 2030 (USD Million)
  • Fig. 67 Class III market, 2018 - 2030 (USD Million)
  • Fig. 68 Drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 69 Class I market, 2018 - 2030 (USD Million)
  • Fig. 70 Class II market, 2018 - 2030 (USD Million)
  • Fig. 71 Class III market, 2018 - 2030 (USD Million)
  • Fig. 72Dental market, 2018 - 2030 (USD Million)
  • Fig. 73 Class I market, 2018 - 2030 (USD Million)
  • Fig. 74 Class II market, 2018 - 2030 (USD Million)
  • Fig. 75 Class III market, 2018 - 2030 (USD Million)
  • Fig. 76 Endoscopy market, 2018 - 2030 (USD Million)
  • Fig. 77 Class I market, 2018 - 2030 (USD Million)
  • Fig. 78 Class II market, 2018 - 2030 (USD Million)
  • Fig. 79 Class III market, 2018 - 2030 (USD Million)
  • Fig. 80 Diabetes care market, 2018 - 2030 (USD Million)
  • Fig. 81 Class I market, 2018 - 2030 (USD Million)
  • Fig. 82 Class II market, 2018 - 2030 (USD Million)
  • Fig. 83 Class III market, 2018 - 2030 (USD Million)
  • Fig. 84 Others market, 2018 - 2030 (USD Million)
  • Fig. 85 Class I market, 2018 - 2030 (USD Million)
  • Fig. 86 Class II market, 2018 - 2030 (USD Million)
  • Fig. 87 Class III market, 2018 - 2030 (USD Million)
  • Fig. 88 U.S. medical device outsourcing market class outlook: Segment Dashboard
  • Fig. 89 U.S. medical device outsourcing market: Class movement analysis
  • Fig. 90 Class I market 2018 - 2030 (USD Million)
  • Fig. 91 Class II market 2018 - 2030 (USD Million
  • Fig. 92 Class III market, 2018 - 2030 (USD Million)